Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2006
12/28/2006WO2006137209A1 Dna, vector, transformant and method for producing apa protein
12/28/2006WO2006136953A2 Method of producing organotypic cell cultures
12/28/2006WO2006136951A2 Murine stem cells and applications thereof
12/28/2006WO2006136351A2 Methods for altering the reactivity of plant cell walls
12/28/2006WO2006136244A2 Use of adipose tissue-derived stromal stem cells in treating fistula
12/28/2006WO2006136164A1 Mutant cells suitable for recombinant polypeptide production
12/28/2006WO2006136114A1 Amniotic cells and methods for use thereof
12/28/2006WO2006136006A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth
12/28/2006WO2006119467A3 Protein activity modification
12/28/2006WO2006117483A3 Synthetic and standardized prion infectuous material, and uses thereof as an infecting inoculum
12/28/2006WO2006113731A3 Bone marrow-derived neurogenic cells and uses thereof
12/28/2006WO2006099480A3 Stress proteins and peptides and methods of use thereof
12/28/2006WO2006099448A3 Accelerated cd8+ t-cell memory after dendritic cell vaccination
12/28/2006WO2006089911A3 Expression cassettes for seed-preferential expression in plants
12/28/2006WO2006083394A3 Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
12/28/2006WO2006083275A3 Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
12/28/2006WO2006074397A3 Cripto binding molecules
12/28/2006WO2006073671A8 Protein activity modification
12/28/2006WO2006040615A3 Differenciation of stem cells for therapeutic use
12/28/2006WO2006036745A3 Il-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses
12/28/2006WO2005103231A3 Dentritic cells charged with toxic substances in order to treat kidney cell carcinomas
12/28/2006WO2005090406A3 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
12/28/2006WO2005079271A3 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
12/28/2006WO2005054295A3 Therapeutic and diagnostic anti-hsp 70 antibodies
12/28/2006WO2005045025A3 Cloning and characterization of 5’ flanking regions of a human aggrecanase-1 gene
12/28/2006WO2003072714A3 Follistatin domain containing proteins
12/28/2006US20060294627 Inbred corn line G0502
12/28/2006US20060294625 Disease-resistant transgenic canola plants; glucosinolate level of <30 mu moles per gram of oil-free solid; oilseed containing <2% erucic acid; extracting crude oil from crushed seeds, refining to rape oil for food use; blackleg resistance; plant cells; genetic engineering
12/28/2006US20060294624 Alfalfa Variety 53V52
12/28/2006US20060294622 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/28/2006US20060294618 imparting virus resistance to plants by silencing a gene encoding a translation initiation factor eIF4E or by overexpressing in a plant a nucleic acid molecule encoding a heterologous eIF4E
12/28/2006US20060294614 Orphan receptors; drug screening; host cells
12/28/2006US20060294613 Mo54 Disruptions, Compositions and Methods Related Thereto
12/28/2006US20060294611 WIP, a WASP-associated protein
12/28/2006US20060294610 Alpha1-3 galactosyltransferase gene and promoter
12/28/2006US20060294609 Production of cloned offspring from cooled carcasses
12/28/2006US20060294604 Model for studying the role of genes in tumor resistance to chemotherapy
12/28/2006US20060294603 Cloning of transgenic animals comprising artificial chromosomes
12/28/2006US20060294602 Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases
12/28/2006US20060293239 Treatment and Diagnosis of Insulin-Resistant States
12/28/2006US20060293230 Expression and secretion of icIL-1 receptor antagonist type II
12/28/2006US20060293225 Gmg-2 polynucleotides and polypeptides and uses thereof
12/28/2006US20060292695 Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells
12/28/2006US20060292694 Reporter hepatocytes and other cells for drug screening and toxicity testing
12/28/2006US20060292693 comprises a heavy chain variable region and a light chain variable region produced by mouse hybridoma cell line 1G3; capable of neutralizing EV71 infection
12/28/2006US20060292692 Nutrient broth for propagation mammalian tissue models for use in nutraceutical discovery, drug screening, pharmacokinetics and transplantation studies
12/28/2006US20060292690 Method of making cell growth surface
12/28/2006US20060292689 CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
12/28/2006US20060292688 System and sequential culture media for in vitro fertilization
12/28/2006US20060292687 Methods for modulating floral organ identity, modulating floral organ number, increasing of meristem size, and delaying flowering time
12/28/2006US20060292673 For degradation of glycosaminoglycans; inhibiting angiogenesis and cellular proliferation; treating cancer, neurodegenerative disease, atherosclerosis and microbial infection
12/28/2006US20060292672 Cell lines for expressing enzyme useful in the preparation of amidated products
12/28/2006US20060292670 Nell peptide expression systems and bone formation activity of nell peptide
12/28/2006US20060292667 Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone
12/28/2006US20060292655 2-O sulfatase compositions and methods of analyzing therewith
12/28/2006US20060292644 Novel tumor-associated marker
12/28/2006US20060292643 Recognition molecules for the treatment and detection of tumours
12/28/2006US20060292636 Quantum (TM) phytase; high sensitivity and specificity for the phytase and are useful in immunoassay methods; capable of detecting low concentrations of phytase
12/28/2006US20060292621 Randomized libraries of zinc finger proteins
12/28/2006US20060292620 Genes with ES cell-specific expression
12/28/2006US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
12/28/2006US20060292587 Polynucleotides encoding insect voltage-gated chloride channel and uses thereof
12/28/2006US20060292577 Neoplasia-specific splice variants and methods
12/28/2006US20060292563 Methods of diagnosing & treating diabetes and insulin resistance
12/28/2006US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception
12/28/2006US20060292546 Herg channel-expressing cell
12/28/2006US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide
12/28/2006US20060292177 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/28/2006US20060292168 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
12/28/2006US20060292166 Vaccine composition comprising Flt3-ligand
12/28/2006US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections
12/28/2006US20060292156 Recombinant lymphocyte expressing Fc receptor for use in targeting and destroying viral infection and tumor tissues
12/28/2006US20060292154 A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same
12/28/2006US20060292152 used for the for the medical diagnosis and treatment of Alzheimer's disease
12/28/2006US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin
12/28/2006US20060292139 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence
12/28/2006US20060292138 Fusion proteins comprising an allergen sequence linked via an IgG hinge region to another polypeptide sequence capable of specifically binding to a native IgG inhibitory receptor containing an immune receptor tyrosine based inhibitory motif
12/28/2006US20060292132 Neuroprotective effective compound
12/28/2006US20060292131 Chondrocyte Therapeutic Delivery System
12/28/2006US20060292130 2-O sulfatase nucleic acid compositions
12/28/2006US20060292129 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof
12/28/2006US20060292128 Methods of treating schizophrenia
12/28/2006US20060292127 Beta cell growth and differentiation
12/28/2006US20060292126 Epidermal and dermal equivalents
12/28/2006US20060292125 Methods for treating ischemic tissue
12/28/2006US20060292123 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles
12/28/2006DE19931819B4 11-Arachidonat-Lipoxygenase-Mutante Arachidonate 11-lipoxygenase mutant
12/28/2006DE102005028899A1 Verfahren zur Erzeugung eines Hautäquivalents A method for producing a skin equivalent
12/28/2006CA2850323A1 Methods and compositions involving mirna and mirna inhibitor molecules
12/28/2006CA2633030A1 Intralesional treatment of psoriasis
12/28/2006CA2620946A1 Amniotic cells and methods for use thereof
12/28/2006CA2613457A1 Use of adipose tissue-derived stromal stem cells in treating fistula
12/28/2006CA2613257A1 A novel biological substance nesfatin and its related substances and uses thereof
12/28/2006CA2613160A1 Methods for altering the reactivity of plant cell walls
12/28/2006CA2612269A1 Method of producing organotypic cell cultures
12/28/2006CA2612252A1 Methods and compositions for gene silencing
12/28/2006CA2612021A1 Compositions and methods for treating and diagnosing cancer
12/28/2006CA2611519A1 Ilt3 binding molecules and uses therefor
12/28/2006CA2609077A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth
12/28/2006CA2607859A1 Murine stem cells and applications thereof